Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 06, 2026 Filed Oct 9, 2026 01:06 UTC |
Workman KurtPresident & CEO
|
Tax withholdingCommon Stock | 20,400 | $4.89 | $99,756.00 |
DisclosureSEC source: 0001868338-26-000004 · wk-form4_1791508013.xml · nonDerivative · entry 1 Workman Kurt · CIK 0001868338 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,190,679 F1 · shares: Represents shares of common stock withheld to satisfy certain tax obligations in connection with the vesting of restricted stock units ("RSUs"). Read SEC document |
| August 12, 2026 Filed Aug 14, 2026 22:09 UTC |
Durr LauraDirector
|
GrantCommon Stock | 26,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001816708-26-000094 · wk-form4_1786745392.xml · nonDerivative · entry 1 Durr Laura · CIK 0001319799 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,454 F1 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| August 12, 2026 Filed Aug 14, 2026 20:10 UTC |
Gonzales MelissaDirector
|
GrantCommon Stock | 26,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001984676-26-000005 · wk-form4_1786738213.xml · nonDerivative · entry 1 Gonzales Melissa · CIK 0001984676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,690 F1 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| August 12, 2026 Filed Aug 14, 2026 20:08 UTC |
Kim John C.Director
|
GrantCommon Stock | 26,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001868479-26-000005 · wk-form4_1786738088.xml · nonDerivative · entry 1 Kim John C. · CIK 0001868479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,811 F1 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| August 12, 2026 Filed Aug 21, 2026 20:11 UTC |
Stoll Marc FDirector
|
GrantCommon Stock | 26,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001416811-26-000004 · wk-form4_1787343101.xml · nonDerivative · entry 2 Stoll Marc F · CIK 0001416811 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,781 F1 · date: This transaction is being reported late due to an administrative oversight. F2 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| August 12, 2026 Filed Aug 21, 2026 20:11 UTC |
BURKE ZANE MDirector
|
GrantCommon Stock | 26,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001213555-26-000004 · wk-form4_1787343096.xml · nonDerivative · entry 2 BURKE ZANE M · CIK 0001213555 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,787 F1 · date: This transaction is being reported late due to an administrative oversight. F2 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| July 08, 2026 Filed Jul 10, 2026 01:30 UTC |
Workman KurtPresident & CEO
|
Tax withholdingCommon Stock | 21,001 | $5.91 | $124,115.91 |
DisclosureSEC source: 0001816708-26-000072 · wk-form4_1783647032.xml · nonDerivative · entry 1 Workman Kurt · CIK 0001868338 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,211,079 Read SEC document |
| April 28, 2026 Filed Apr 30, 2026 20:33 UTC |
Workman KurtPresident & CEO
|
GrantCommon Stock | 850,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001868338-26-000002 · wk-form4_1777581221.xml · nonDerivative · entry 6 Workman Kurt · CIK 0001868338 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,232,080 F5 · shares: Represents restricted stock units which will vest as follows: 1/12th of the total original number of restricted stock units shall vest on July 6, 2026 and 1/12th of the total original number of restricted stock units shall vest on the same day of every 3rd month thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date. Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 23:18 UTC |
Crawford AmandaChief Financial Officer
|
Tax withholdingCommon Stock | 141 | $5.66 | $798.06 |
DisclosureSEC source: 0001816708-26-000025 · wk-form4_1776467916.xml · nonDerivative · entry 1 Crawford Amanda · CIK 0002030797 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,679 F1 · shares: Represents shares of common stock withheld to satisfy certain tax obligations in connection with the vesting of restricted stock units ("RSUs"). Read SEC document |
| April 03, 2026 Filed Apr 7, 2026 22:00 UTC |
Crawford AmandaChief Financial Officer
|
Tax withholdingCommon Stock | 9,242 | $5.10 | $47,134.20 |
DisclosureSEC source: 0002030797-26-000002 · wk-form4_1775599249.xml · nonDerivative · entry 2 Crawford Amanda · CIK 0002030797 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,820 F4 · shares: Represents shares of common stock withheld to satisfy certain tax obligations in connection with the vesting of restricted stock units ("RSUs") in connection with the acquisition reported in this Report. Read SEC document |
| April 03, 2026 Filed Apr 7, 2026 22:00 UTC |
Crawford AmandaChief Financial Officer
|
GrantCommon Stock | 32,032 | $4.92 | $157,533.38 |
DisclosureSEC source: 0002030797-26-000002 · wk-form4_1775599249.xml · nonDerivative · entry 1 Crawford Amanda · CIK 0002030797 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,062 F1 · shares: Reflects shares of Class A common stock ('Shares') issued to the Reporting Person in lieu of her earned 2025 annual incentive bonus, in an amount equal to $157,531, pursuant to a one-time election approved by the Compensation Committee of the Issuer's Board of Directors on March 25, 2026. The acquisition of these Shares was specifically approved in advance by the Compensation Committee in accordance with Rule 16b-3(d) and is therefore an exempt acquisition from the Issuer. F2 · price: In accordance with the terms of the election, the number of Shares was determined by dividing the cash value of $157,531 by the volume weighted average price (VWAP) of the Shares for the five consecutive trading days ending on the trading day immediately preceding the date of issuance. F3 · balance_after: Includes shares acquired in the Company's employee stock purchase plan ("ESPP"). Read SEC document |
| March 25, 2026 Filed Mar 28, 2026 01:50 UTC |
Crawford AmandaChief Financial Officer
|
Tax withholdingCommon Stock | 19,191 | $5.11 | $98,066.01 |
DisclosureSEC source: 0002030797-26-000001 · wk-form4_1774662607.xml · nonDerivative · entry 1 Crawford Amanda · CIK 0002030797 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,134 F1 · shares: Represents shares of common stock withheld to satisfy certain tax obligations in connection with the vesting of previously reported restricted stock units ("RSUs"). Read SEC document |
| February 27, 2026 Filed Apr 30, 2026 20:30 UTC |
Crawford AmandaChief Financial Officer
|
SaleCommon Stock | 6,892 | $11.50 | $79,258.00 |
DisclosureSEC source: 0002030797-26-000004 · wk-form4_1777581056.xml · nonDerivative · entry 8 Crawford Amanda · CIK 0002030797 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,800 F1 · date: This transaction is being reported late due to an administrative oversight. F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs"). Read SEC document |
| February 26, 2026 Filed Apr 30, 2026 20:46 UTC |
Harris JonathanFormer President & CEO
|
SaleCommon Stock | 12,676 | $11.50 | $145,774.00 |
DisclosureSEC source: 0001698253-26-000004 · wk-form4_1777581980.xml · nonDerivative · entry 8 Harris Jonathan · CIK 0001698253 · Former President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 339,336 F1 · date: This transaction is being reported late due to an administrative oversight. F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs"). Read SEC document |
| February 26, 2026 Filed Apr 30, 2026 20:46 UTC |
Harris JonathanFormer President & CEO
|
GrantCommon Stock | 41,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001698253-26-000004 · wk-form4_1777581980.xml · nonDerivative · entry 7 Harris Jonathan · CIK 0001698253 · Former President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 352,012 F1 · date: This transaction is being reported late due to an administrative oversight. F4 · shares: Represents shares of Common Stock earned with respect to a performance-based RSU granted on November 30, 2025. The Issuer's compensation committee certified the first tranche of attainment of the performance measures on February 26, 2026. These RSUs become vested upon certification of performance measures. This portion is one of six equal tranches, each of which has its own vesting goal based on achievement of cumulative net revenue over the period beginning on January 1, 2025 and ending on December 31, 2028, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| February 25, 2026 Filed Apr 30, 2026 20:30 UTC |
Crawford AmandaChief Financial Officer
|
GrantCommon Stock | 20,833 | $0.00 | $0.00 |
DisclosureSEC source: 0002030797-26-000004 · wk-form4_1777581056.xml · nonDerivative · entry 7 Crawford Amanda · CIK 0002030797 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,692 F1 · date: This transaction is being reported late due to an administrative oversight. F4 · shares: Represents shares of Common Stock earned with respect to a performance-based RSU granted on November 30, 2025. The Issuer's compensation committee certified the first tranche of attainment of the performance measures on February 26, 2026. These RSUs become vested upon certification of performance measures. This portion is one of six equal tranches, each of which has its own vesting goal based on achievement of cumulative net revenue over the period beginning on January 1, 2025 and ending on December 31, 2028, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| February 17, 2026 Filed Apr 30, 2026 20:46 UTC |
Harris JonathanFormer President & CEO
|
SaleCommon Stock | 3,540 | $10.65 | $37,701.00 |
DisclosureSEC source: 0001698253-26-000004 · wk-form4_1777581980.xml · nonDerivative · entry 6 Harris Jonathan · CIK 0001698253 · Former President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,346 F1 · date: This transaction is being reported late due to an administrative oversight. F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs"). Read SEC document |
| January 20, 2026 Filed Jan 23, 2026 02:23 UTC |
Crawford AmandaChief Financial Officer
|
SaleCommon Stock | 183 | $13.33 | $2,439.39 |
DisclosureSEC source: 0001628280-26-003171 · wk-form4_1769134982.xml · nonDerivative · entry 1 Crawford Amanda · CIK 0002030797 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,325 F1 · kind: The sales reported on this Form 4 represent shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units. Read SEC document |
| January 20, 2026 Filed Jan 23, 2026 02:22 UTC |
Harris JonathanPresident and CEO
|
SaleCommon Stock | 2,311 | $13.33 | $30,805.63 |
DisclosureSEC source: 0001628280-26-003170 · wk-form4_1769134955.xml · nonDerivative · entry 1 Harris Jonathan · CIK 0001698253 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 264,396 F1 · kind: The sales reported on this Form 4 represent shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units. Read SEC document |
| November 17, 2025 Filed Apr 30, 2026 20:46 UTC |
Harris JonathanFormer President & CEO
|
SaleCommon Stock | 3,423 | $10.49 | $35,907.27 |
DisclosureSEC source: 0001698253-26-000004 · wk-form4_1777581980.xml · nonDerivative · entry 5 Harris Jonathan · CIK 0001698253 · Former President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 313,886 F1 · date: This transaction is being reported late due to an administrative oversight. F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs"). Read SEC document |
| October 16, 2025 Filed Apr 30, 2026 22:51 UTC |
Gonzales MelissaDirector
|
GrantCommon Stock | 18,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001984676-26-000002 · wk-form4_1777589466.xml · nonDerivative · entry 1 Gonzales Melissa · CIK 0001984676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,905 F1 · date: This transaction is being reported late due to an administrative oversight. F2 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| October 16, 2025 Filed Apr 30, 2026 22:31 UTC |
Kim John C.Director
|
GrantCommon Stock | 18,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001868479-26-000002 · wk-form4_1777588293.xml · nonDerivative · entry 1 Kim John C. · CIK 0001868479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,026 F1 · date: This transaction is being reported late due to an administrative oversight. F2 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| October 16, 2025 Filed Apr 30, 2026 20:46 UTC |
Harris JonathanFormer President & CEO
|
SaleCommon Stock | 1,851 | $8.75 | $16,196.25 |
DisclosureSEC source: 0001698253-26-000004 · wk-form4_1777581980.xml · nonDerivative · entry 4 Harris Jonathan · CIK 0001698253 · Former President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,309 F1 · date: This transaction is being reported late due to an administrative oversight. F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs"). Read SEC document |
| October 16, 2025 Filed Apr 30, 2026 20:30 UTC |
Crawford AmandaChief Financial Officer
|
SaleCommon Stock | 149 | $8.75 | $1,303.75 |
DisclosureSEC source: 0002030797-26-000004 · wk-form4_1777581056.xml · nonDerivative · entry 6 Crawford Amanda · CIK 0002030797 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,859 F1 · date: This transaction is being reported late due to an administrative oversight. F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs"). Read SEC document |
| October 16, 2025 Filed May 2, 2026 00:50 UTC |
Durr LauraDirector
|
GrantCommon Stock | 18,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001816708-26-000033 · wk-form4_1777683007.xml · nonDerivative · entry 1 Durr Laura · CIK 0001319799 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,669 F1 · date: This transaction is being reported late due to an administrative oversight. F2 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| October 16, 2025 Filed Aug 21, 2026 20:11 UTC |
Stoll Marc FDirector
|
GrantCommon Stock | 18,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001416811-26-000004 · wk-form4_1787343101.xml · nonDerivative · entry 1 Stoll Marc F · CIK 0001416811 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,996 F1 · date: This transaction is being reported late due to an administrative oversight. F2 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| October 16, 2025 Filed Aug 21, 2026 20:11 UTC |
BURKE ZANE MDirector
|
GrantCommon Stock | 18,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001213555-26-000004 · wk-form4_1787343096.xml · nonDerivative · entry 1 BURKE ZANE M · CIK 0001213555 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,002 F1 · date: This transaction is being reported late due to an administrative oversight. F2 · shares: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| October 10, 2025 Filed Oct 16, 2025 01:14 UTC |
Workman KurtDirector
|
Disposition to issuerWarrant (Right to Buy) · Derivative | 131,195 | $0.00 Strike: $4.44 | $0.00 |
DisclosureSEC source: 0001628280-25-045154 · wk-form4_1760577238.xml · derivative · entry 2 Workman Kurt · CIK 0001868338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 131,195 shares Expires 2028-02-17 F1 · kind: On October 10, 2025, the Reporting Person exchanged warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 shares per warrant. Read SEC document |
| October 10, 2025 Filed Oct 16, 2025 01:14 UTC |
Workman KurtDirector
|
GrantCommon Stock | 80,235 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-045154 · wk-form4_1760577238.xml · nonDerivative · entry 1 Workman Kurt · CIK 0001868338 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 419,004 F1 · kind: On October 10, 2025, the Reporting Person exchanged warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 shares per warrant. F1 · price: On October 10, 2025, the Reporting Person exchanged warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 shares per warrant. Read SEC document |
| October 10, 2025 Filed Oct 16, 2025 01:13 UTC |
Kim John C.Director
|
Disposition to issuerWarrant (Right to Buy) · Derivative | 48,621 | $0.00 Strike: $4.09 | $0.00 |
DisclosureSEC source: 0001628280-25-045153 · wk-form4_1760577208.xml · derivative · entry 3 Kim John C. · CIK 0001868479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 48,621 shares Expires 2029-03-01 F1 · kind: On October 10, 2025, the Reporting Person exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. Read SEC document |
| October 10, 2025 Filed Oct 16, 2025 01:13 UTC |
Kim John C.Director
|
Disposition to issuerWarrant (Right to Buy) · Derivative | 131,195 | $0.00 Strike: $4.44 | $0.00 |
DisclosureSEC source: 0001628280-25-045153 · wk-form4_1760577208.xml · derivative · entry 2 Kim John C. · CIK 0001868479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 131,195 shares Expires 2028-02-17 F1 · kind: On October 10, 2025, the Reporting Person exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. Read SEC document |
| October 10, 2025 Filed Oct 16, 2025 01:13 UTC |
Kim John C.Director
|
GrantCommon Stock | 107,626 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-045153 · wk-form4_1760577208.xml · nonDerivative · entry 1 Kim John C. · CIK 0001868479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,030 F1 · kind: On October 10, 2025, the Reporting Person exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. F1 · price: On October 10, 2025, the Reporting Person exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. Read SEC document |
| October 10, 2025 Filed Oct 16, 2025 01:12 UTC |
Trilogy Equity Partners, LLC10% owner
|
ConversionWarrant (Right to Buy) · Derivative | 444,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-045152 · wk-form4_1760577175.xml · derivative · entry 3 Trilogy Equity Partners, LLC · CIK 0001875623 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 444,601 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 10, 2025, the Reporting Person exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. F1 · kind: On October 10, 2025, the Reporting Person exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. Read SEC document |
| October 10, 2025 Filed Oct 16, 2025 01:12 UTC |
Trilogy Equity Partners, LLC10% owner
|
ConversionWarrant (Right to Buy) · Derivative | 712,915 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-045152 · wk-form4_1760577175.xml · derivative · entry 2 Trilogy Equity Partners, LLC · CIK 0001875623 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 712,915 shares Expires 2028-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On October 10, 2025, the Reporting Person exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. F1 · kind: On October 10, 2025, the Reporting Person exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. Read SEC document |
| October 10, 2025 Filed Oct 16, 2025 01:12 UTC |
Trilogy Equity Partners, LLC10% owner
|
ConversionCommon Stock | 686,469 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-045152 · wk-form4_1760577175.xml · nonDerivative · entry 1 Trilogy Equity Partners, LLC · CIK 0001875623 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,567,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On October 10, 2025, the Reporting Person exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. F1 · price: On October 10, 2025, the Reporting Person exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. Read SEC document |
| October 10, 2025 Filed Oct 15, 2025 22:56 UTC |
Eclipse Continuity GP I, LLCDirector · 10% owner · Director by Deputization
Eclipse Early Growth Fund I, L.P.Director · 10% owner · Director by Deputization
Eclipse Early Growth GP I, LLCDirector · 10% owner · Director by Deputization
Eclipse Continuity Fund I, L.P.Director · 10% owner · Director by Deputization
Eclipse Ventures GP I, LLCDirector · 10% owner · Director by Deputization
Eclipse Ventures Fund I, L.P.Director · 10% owner · Director by Deputization
|
Disposition to issuerSeries B Warrants (Right to Purchase Shares of Common Stock) · Derivative | 1,166,935 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-240517 · ownership.xml · derivative · entry 5 Eclipse Continuity GP I, LLC · CIK 0001675124 · Director · 10% owner · Director by Deputization Eclipse Early Growth Fund I, L.P. · CIK 0001877287 · Director · 10% owner · Director by Deputization Eclipse Early Growth GP I, LLC · CIK 0001876955 · Director · 10% owner · Director by Deputization Eclipse Continuity Fund I, L.P. · CIK 0001675126 · Director · 10% owner · Director by Deputization Eclipse Ventures GP I, LLC · CIK 0001843678 · Director · 10% owner · Director by Deputization Eclipse Ventures Fund I, L.P. · CIK 0001641394 · Director · 10% owner · Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 1,166,935 shares Expires not disclosed F1 · derivative.exercise_price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · kind: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · derivative.exercise_date: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · derivative.expiration_date: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F2 · ownership.nature: The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| October 10, 2025 Filed Oct 15, 2025 22:56 UTC |
Eclipse Continuity GP I, LLCDirector · 10% owner · Director by Deputization
Eclipse Early Growth Fund I, L.P.Director · 10% owner · Director by Deputization
Eclipse Early Growth GP I, LLCDirector · 10% owner · Director by Deputization
Eclipse Continuity Fund I, L.P.Director · 10% owner · Director by Deputization
Eclipse Ventures GP I, LLCDirector · 10% owner · Director by Deputization
Eclipse Ventures Fund I, L.P.Director · 10% owner · Director by Deputization
|
Disposition to issuerSeries A Warrants (Right to Purchase Shares of Common Stock) · Derivative | 5,300,291 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-240517 · ownership.xml · derivative · entry 4 Eclipse Continuity GP I, LLC · CIK 0001675124 · Director · 10% owner · Director by Deputization Eclipse Early Growth Fund I, L.P. · CIK 0001877287 · Director · 10% owner · Director by Deputization Eclipse Early Growth GP I, LLC · CIK 0001876955 · Director · 10% owner · Director by Deputization Eclipse Continuity Fund I, L.P. · CIK 0001675126 · Director · 10% owner · Director by Deputization Eclipse Ventures GP I, LLC · CIK 0001843678 · Director · 10% owner · Director by Deputization Eclipse Ventures Fund I, L.P. · CIK 0001641394 · Director · 10% owner · Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 5,300,291 shares Expires not disclosed F1 · derivative.exercise_price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · kind: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · derivative.exercise_date: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · derivative.expiration_date: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F2 · ownership.nature: The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| October 10, 2025 Filed Oct 15, 2025 22:56 UTC |
Eclipse Continuity GP I, LLCDirector · 10% owner · Director by Deputization
Eclipse Early Growth Fund I, L.P.Director · 10% owner · Director by Deputization
Eclipse Early Growth GP I, LLCDirector · 10% owner · Director by Deputization
Eclipse Continuity Fund I, L.P.Director · 10% owner · Director by Deputization
Eclipse Ventures GP I, LLCDirector · 10% owner · Director by Deputization
Eclipse Ventures Fund I, L.P.Director · 10% owner · Director by Deputization
|
GrantCommon Stock | 3,898,906 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-240517 · ownership.xml · nonDerivative · entry 1 Eclipse Continuity GP I, LLC · CIK 0001675124 · Director · 10% owner · Director by Deputization Eclipse Early Growth Fund I, L.P. · CIK 0001877287 · Director · 10% owner · Director by Deputization Eclipse Early Growth GP I, LLC · CIK 0001876955 · Director · 10% owner · Director by Deputization Eclipse Continuity Fund I, L.P. · CIK 0001675126 · Director · 10% owner · Director by Deputization Eclipse Ventures GP I, LLC · CIK 0001843678 · Director · 10% owner · Director by Deputization Eclipse Ventures Fund I, L.P. · CIK 0001641394 · Director · 10% owner · Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 5,665,669 F1 · kind: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F2 · ownership.nature: The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Mr. Susan is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| October 10, 2025 Filed Oct 15, 2025 22:51 UTC |
Susan LiorDirector · 10% owner
|
Disposition to issuerSeries B Warrants (Right to Purchase Shares of Common Stock) · Derivative | 1,166,935 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-240511 · ownership.xml · derivative · entry 5 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 1,166,935 shares Expires not disclosed F1 · derivative.exercise_price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · kind: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · derivative.exercise_date: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · derivative.expiration_date: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F2 · ownership.nature: The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. The Reporting Person is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and the Reporting Person disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| October 10, 2025 Filed Oct 15, 2025 22:51 UTC |
Susan LiorDirector · 10% owner
|
Disposition to issuerSeries A Warrants (Right to Purchase Shares of Common Stock) · Derivative | 5,300,291 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-240511 · ownership.xml · derivative · entry 4 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 5,300,291 shares Expires not disclosed F1 · derivative.exercise_price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · kind: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · derivative.exercise_date: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · derivative.expiration_date: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F2 · ownership.nature: The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. The Reporting Person is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and the Reporting Person disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| October 10, 2025 Filed Oct 15, 2025 22:51 UTC |
Susan LiorDirector · 10% owner
|
GrantCommon Stock | 3,898,906 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-240511 · ownership.xml · nonDerivative · entry 1 Susan Lior · CIK 0001832895 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 5,665,669 F1 · kind: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F1 · price: On October 10, 2025, Eclipse Early Growth Fund I, L.P. ("Eclipse EGF I") exchanged (a) warrants to purchase shares of Class A common stock, par value $0.0001 per share, of the Company (the "Common Stock"), that were initially issued in February 2023 in connection with the Company's issuance and sale of Series A Convertible Preferred Stock and (b) warrants to purchase shares of Common Stock that were initially issued in February 2024 in connection with the Company's issuance and sale of Series B Convertible Preferred Stock for the shares of Common Stock reported herein at a ratio of approximately 0.61 and 0.56 shares per warrant, respectively. The disposition or deemed disposition of the warrants and any shares of Common Stock that may have been be acquired upon exercise of such warrants and the acquisition of Common Stock in this exchange were exempted from Section 16(b) of the Act pursuant to Rule 16b-3 thereunder. F2 · ownership.nature: The securities are held of record by Eclipse EGF I. Eclipse Early Growth GP I, LLC ("Eclipse EG GP I") is the general partner of Eclipse EGF I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. The Reporting Person is the sole managing member of Eclipse EG GP I and may be deemed to have voting and dispositive power over the shares held by Eclipse EGF I. Eclipse EG GP I and the Reporting Person disclaim beneficial ownership of the shares held by Eclipse EGF I except to the extent of their respective pecuniary interests therein, if any. Read SEC document |
| October 03, 2025 Filed Apr 30, 2026 20:33 UTC |
Workman KurtPresident & CEO
|
SaleCommon Stock | 49,056 | $8.46 | $415,013.76 |
DisclosureSEC source: 0001868338-26-000002 · wk-form4_1777581221.xml · nonDerivative · entry 5 Workman Kurt · CIK 0001868338 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 382,080 F1 · date: This transaction is being reported late due to an administrative oversight. F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs"). Read SEC document |
| September 30, 2025 Filed Apr 30, 2026 20:46 UTC |
Harris JonathanFormer President & CEO
|
GrantCommon Stock | 60,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001698253-26-000004 · wk-form4_1777581980.xml · nonDerivative · entry 3 Harris Jonathan · CIK 0001698253 · Former President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 319,160 F1 · date: This transaction is being reported late due to an administrative oversight. F3 · shares: Reflects RSUs for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on December 15, 2026, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| September 30, 2025 Filed Apr 30, 2026 20:33 UTC |
Workman KurtPresident & CEO
|
GrantCommon Stock | 14,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001868338-26-000002 · wk-form4_1777581221.xml · nonDerivative · entry 4 Workman Kurt · CIK 0001868338 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 431,136 F1 · date: This transaction is being reported late due to an administrative oversight. F4 · shares: Reflects shares of the Issuer delivered to the reporting person upon satisfaction of performance criteria underlying an award of performance-based RSUs ("PSUs") granted to the reporting person on March 15, 2022. Read SEC document |
| September 30, 2025 Filed Apr 30, 2026 20:30 UTC |
Crawford AmandaChief Financial Officer
|
GrantCommon Stock | 48,019 | $0.00 | $0.00 |
DisclosureSEC source: 0002030797-26-000004 · wk-form4_1777581056.xml · nonDerivative · entry 5 Crawford Amanda · CIK 0002030797 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,008 F1 · date: This transaction is being reported late due to an administrative oversight. F3 · shares: Reflects RSUs for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on December 8, 2026, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| September 17, 2025 Filed Apr 30, 2026 20:33 UTC |
Workman KurtPresident & CEO
|
SaleCommon Stock | 1,014 | $7.25 | $7,351.50 |
DisclosureSEC source: 0001868338-26-000002 · wk-form4_1777581221.xml · nonDerivative · entry 3 Workman Kurt · CIK 0001868338 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 417,038 F1 · date: This transaction is being reported late due to an administrative oversight. F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs"). Read SEC document |
| September 10, 2025 Filed Apr 30, 2026 20:30 UTC |
Crawford AmandaChief Financial Officer
|
SaleCommon Stock | 4,225 | $7.06 | $29,828.50 |
DisclosureSEC source: 0002030797-26-000004 · wk-form4_1777581056.xml · nonDerivative · entry 4 Crawford Amanda · CIK 0002030797 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,989 F1 · date: This transaction is being reported late due to an administrative oversight. F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs"). Read SEC document |
| August 19, 2025 Filed Apr 30, 2026 20:46 UTC |
Harris JonathanFormer President & CEO
|
SaleCommon Stock | 3,315 | $7.72 | $25,591.80 |
DisclosureSEC source: 0001698253-26-000004 · wk-form4_1777581980.xml · nonDerivative · entry 2 Harris Jonathan · CIK 0001698253 · Former President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 259,136 F1 · date: This transaction is being reported late due to an administrative oversight. F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs"). Read SEC document |
| July 17, 2025 Filed Apr 30, 2026 20:46 UTC |
Harris JonathanFormer President & CEO
|
SaleCommon Stock | 1,945 | $8.03 | $15,618.35 |
DisclosureSEC source: 0001698253-26-000004 · wk-form4_1777581980.xml · nonDerivative · entry 1 Harris Jonathan · CIK 0001698253 · Former President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262,451 F1 · date: This transaction is being reported late due to an administrative oversight. F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs"). Read SEC document |
| July 17, 2025 Filed Apr 30, 2026 20:30 UTC |
Crawford AmandaChief Financial Officer
|
SaleCommon Stock | 157 | $8.03 | $1,260.71 |
DisclosureSEC source: 0002030797-26-000004 · wk-form4_1777581056.xml · nonDerivative · entry 3 Crawford Amanda · CIK 0002030797 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,214 F1 · date: This transaction is being reported late due to an administrative oversight. F2 · shares: Represents shares automatically sold in a non-discretionary transaction to cover taxes and fees in connection with the vesting and settlement of restricted stock units ("RSUs"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.